PAG
IMGN

Private Advisor Group’s Immunogen Inc IMGN Stock Holding History

Private Advisor Group’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-267
Closed -$1K – 3619
2020
Q2 		$1K Buy
+267
New +$1.14K ﹤0.01% 3788
2019
Q1 		– Sell
-11,600
Closed -$56K – 1618
2018
Q4 		$56K Buy
+11,600
New +$70.4K ﹤0.01% 1319
2018
Q3 		– Sell
-13,304
Closed -$131K – 1663
2018
Q2 		$131K Buy
+13,304
New +$140K ﹤0.01% 1239
2017
Q4 		– Sell
-11,559
Closed -$77K – 1440
2017
Q3 		$77K Buy
+11,559
New +$76.8K ﹤0.01% 1425

Other funds holding IMGN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Private Advisor Group's IMGN Position: Q3 2020 in Review

Private Advisor Group sold out of Immunogen Inc (IMGN) in Q3 2020, closing a stake of 267 shares — an estimated $1K sold.

Private Advisor Group first reported a position in IMGN in Q3 2017 and held it in 4 quarters. The position peaked at $131K in Q2 2018. 185 funds tracked by Wall St. Rank hold IMGN as of Q3 2020.

  • Private Advisor Group reported no remaining Immunogen Inc position as of Q3 2020 after selling out during the quarter.
  • Private Advisor Group sold 267 Immunogen Inc shares in Q3 2020, an estimated $1K.
  • Private Advisor Group first reported a position in Immunogen Inc in Q3 2017 and held it in 4 quarters.
  • Private Advisor Group's Immunogen Inc position peaked at $131K in Q2 2018.
  • 185 funds tracked by Wall St. Rank held Immunogen Inc as of Q3 2020.

Based on Private Advisor Group's 13F filing for Q3 2020, filed 2 Nov 2020.